None
Quote | Corcept Therapeutics Incorporated (NASDAQ:CORT)
Last: | $33.34 |
---|---|
Change Percent: | -1.79% |
Open: | $32.93 |
Close: | $33.34 |
High: | $33.685 |
Low: | $32.56 |
Volume: | 941,859 |
Last Trade Date Time: | 07/16/2024 03:00:00 am |
News | Corcept Therapeutics Incorporated (NASDAQ:CORT)
2024-07-16 11:50:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. With large-cap valuati...
2024-06-26 06:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips I’m on the hunt for ‘Strong Buy’ biotech stocks . According to Finviz.com, there are 680 U.S.-listed biotech stocks. Of those, 73 have a market capitalization o...
Message Board Posts | Corcept Therapeutics Incorporated (NASDAQ:CORT)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $CORT News Article - Corcept Therapeutics (CORT) Q4 2021 Earnings Call Transcript | whytestocks | investorshangout | 02/16/2022 3:10:50 PM |
whytestocks: $CORT News Article - Corcept Therapeutics Announces Waiver of Condition to its Tender O | whytestocks | investorshangout | 12/15/2021 4:40:47 PM |
The Fed. Cir. affirmed the decision of the | north40000 | investorshub | 12/07/2021 10:08:54 PM |
On 8/24/21, a class action survived a motion | jgrabar | investorshub | 11/12/2021 4:03:59 PM |
whytestocks: $CORT News Article - Corcept Therapeutics Incorporated (CORT) Q2 2021 Earnings Call Tra | whytestocks | investorshangout | 07/30/2021 4:10:46 PM |
News, Short Squeeze, Breakout and More Instantly...
Corcept Therapeutics Incorporated Company Name:
CORT Stock Symbol:
NASDAQ Market:
Corcept Therapeutics Incorporated Website:
Results from the CATALYST clinical trial were presented at the American Diabetes Association’s 84 th Scientific Sessions at a featured plenary session titled: “Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes” With 1,055 patients enro...
2024-06-12 10:00:07 ET Edward Nash from Canaccord Genuity issued a price target of $38.00 for CORT on 2024-06-12 07:45:00. The adjusted price target was set to $38.00. At the time of the announcement, CORT was trading at $32.79. The overall price target consensus is at $...